Nick Ackerman

This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded funds. Nick has previously held Series 7 and Series 66 licenses and has been investing personally […]

This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded funds. Nick has previously held Series 7 and Series 66 licenses and has been investing personally

This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded funds. Nick has previously held Series 7 and Series 66 licenses and has been investing personally

JRI: Discount Narrows But Attractive Underlying Assets (Rating Downgrade) Source link Nick Ackerman

Richard Drury Written by Nick Ackerman, co-produced by Stanford Chemist BlackRock Enhanced Equity Dividend Fund (NYSE:BDJ) has been performing well since our last update. Even outpacing the S&P 500 Index in this relatively short period of time. That index isn’t

MicroStockHub Written by Nick Ackerman, co-produced by Stanford Chemist The Virtus Total Return Fund (NYSE:ZTR) is a closed-end fund that invests in a portfolio of utilities and fixed-income securities. The fund is continuing to trade at a wide discount, as

peshkov Written by Nick Ackerman, co-produced by Stanford Chemist Earlier this year we covered Voya Global Advantaged and Premium Opportunity Fund (NYSE:IGA), noting that the fund made a switch to a monthly distribution. Also, at that time, the fund increased